OncoSec Medical Inc (ONCSQ)

[chickpea598]

In two weeks we will know more regarding TNBC plans when AACR happens. Next few months will reveal just how compelling Oncosec valuation is to Big Pharma. PISCES for melanoma and TNBC are the current value drivers. If all is positive in the near-term we will see Oncosec hitting the conservative price targets of $5 to $6. Longer-term can't be determined yet regarding multi-gene construct. I believe PISCES and TNBC positive news would be enough to trigger a buyout or major licensing deals at this point though. Licensing deals with major cash and the share price would move higher than the current price targets. Positive trial news with no licensing deal or buyout and we will see a pop and drop with the share price....and more equity raises to fund trials. Upfront money or buyout is the hope here.